MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER\'S DISEASE WITH NANOLITHIUM
20 Nov 2024 17:45 CET
Issuer
MEDESIS PHARMA S.A.
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
16165_1299301_MedesisPharma_CP_FinetudecliniqueAD_20241120_EN_DEF.pdf
Source
MEDESIS PHARMA
Provider
Les Echos
Company Name
MEDESIS PHARMA S.A.
ISIN
FR0010844464
Symbol
ALMDP
Market
Euronext Growth